MedTech Frontiers


Welcome to MedTech Frontiers

A Monthly Event Hosted by Triple Ring Technologies

MedTech Frontiers is a continuing series of free events for medical device and life science investors, entrepreneurs, and technologists. Please join us for evenings of food, conversation, and presentations by Silicon Valley luminaries held on the first Thursday of each month.

Sign up to Receive Future Invitations
Register for the Upcoming Event

If you are unable to attend this event, but would like to be added to our list, please e-mail us
Thanks for your Patience, We're Rolling Out a New System: Online Event Registration by Constant Contact

MedTech Frontiers
A Biomedical Fireside Chat: Lessons Learned and Promising Leads for Drug-Eluting Stents

 Date:  Thursday, December 3, 2015

Time:  6:00 pm - 9:00 pm (presentation begins at 6:45pm)

Triple Ring Technologies
39655 Eureka Drive
Newark, CA 94560

Speaker: Syed Hossainy, PhD

Cost: The seminar is free of charge, but advance registration is required.

On-Site registration:  A limited number of on-site registrations may be available.

About the Seminar: 

To close out the 2015 MedTech Frontiers series, Dr. Syed Hossainy will join us for a fireside chat about his work on drug eluting stents (DES). Considered by many to be a major breakthrough in interventional cardiology, DES are primarily used in patients with atherosclerosis, to open up narrowed and obstructed coronary arteries. This type of stent is coated with medicine which prevents the growth of scar tissue in the artery, which would otherwise likely narrow. While the United States has been home to over 8 million coronary interventions since 2001, it appears that trends in DES are not fully defined. This is due in part to the increased use by patient subgroups at risk of restenosis versus the decreased use in subgroups at risk of thrombosis or bleeding, as well as those vulnerable to discriminant care (e.g. the elderly and patients with Medicaid and self-pay). Dr. Hossainy will speak to the technology around DES, corresponding clinical data, and will share lessons learned in the field. He will also cover a shortlist of unmet clinical needs and illuminate a few promising technologies on the interventional cardiology horizon.

About the Presenter:

Syed Hossainy, PhD, is a senior research fellow at Abbott Vascular. Syed was recently the head of Abbott Vascular's innovation incubator group with a vision of targeted innovation optimizing short term and long-term business growth options. From 2007 to 2013, the group delivered 10 successful proof-of feasibility projects, including the first ever Bioabsorbable Vascular Scaffold for peripheral vasculature, clinically showing product feasibility. Syed's technical contributions include biomaterials for clinical application, local drug delivery, and mathematical modeling in biomedical therapy. In addition, Syed leads the innovation strategy at Abbott by partnering with technical leadership, and both business and legal functions. Syed has more than 300 issued patents, and over 400 patents pending (with the USPTO) in the area of cardiovascular implants, drug delivery, and biomaterials application. He also delivered over 20 invited lectures and keynotes at world congresses, more than 75 additional podium and poster presentations, and has 15 peer-reviewed journal publications. Dr. Hossainy is currently an adjunct professor in the Department of Bioengineering at UC Berkeley, and has been a Research Fellow at the Institute of Computational Engineering and Sciences (ICES) since 2009, and a Research Affiliate at the Harvard-MIT Biomedical Engineering Center since 2006. Dr. Hossainy holds a M.Sc and a Ph.D. in Chemical Engineering from the University of Texas at Austin, in addition to a B.Sc in Chemical Engineering from Bangladesh University of Engineering and Technology.

About Us Menu
Coming Events

Our monthly MedTech Frontiers gathering features a prominent thought-leader. Please join us. Click here for more information.

Latest News

Triple Ring Technologies is currently looking for a few exceptionally talented individuals.  For more information, click here.

About Us Menu

Contact Us